MedPath

SANDOZ LEFLUNOMIDE

SANDOZ LEFLUNOMIDE

Approved
DIN Number

02283972

Drug Class

Human

Market Date

Aug 15, 2006

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02283972
AIG Number0140182002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AK01 LEFLUNOMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:24.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEFLUNOMIDEActive
Strength: 20 MG
Monograph: LEFLUNOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.